Tag Archives: HHS

Letter from Dr. Norbert regarding COVID-19

Posted on September 18, 2020 by D. Posnett MD

COVID-19’s Human Toll, New Knowledge, Challenges Ahead  Several of my patients have died of COVID; others hospitalized butt survived. Many more were COVID positive and for reasons that we are only beginning to understand survived with few aftereffects. Food insecurity … Continue reading →

Posted in Coronavirus, Health Care, Trump, Zeldin | Tagged , , | 1 Comment

Labradoodle dog breeder heads HHS response to the coronavirus

Posted on April 23, 2020 by D. Posnett MD

Submitted by Peggy Backman: Rebecca Ballhaus @rebeccaballhaus FDA chief Stephen Hahn asked HHS (Health and Human Services) in January if he could contact companies about possible shortages of PPE and other equipment. He was told no. Azar told associates such … Continue reading →

Posted in Coronavirus, Health Care, Trump, Uncategorized | Tagged , , , , , , | Leave a comment

Trump Undercuts ACA with New Plan Options

Posted on October 19, 2017 by D. Posnett MD

Author Shannon Muchmore @stmuchmore Published Oct. 12, 2017 Dive Brief: President Donald Trump signed an executive order Thursday that rolls back a number of Affordable Care Act (ACA) provisions that set minimum requirements for health plans. The order will allow … Continue reading →

Posted in ACA, Health Care, trumpcare, Uncategorized, Zeldin | Tagged , , , , | Leave a comment

Tom Price Must Go

Posted on September 29, 2017 by D. Posnett MD

    Posted on their website where you can also sign up in support.  Here is the message from the National Physician’s Alliance: We’ve been here before. Almost a year ago, we opposed the nomination of Dr. Tom Price for … Continue reading →

Posted in ACA, AHCA, Health Care, trumpcare, Uncategorized | Tagged , , | 1 Comment

Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia.

Posted on June 1, 2017 by bcolbath42

Before he was named Trump’s health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement. by Robert Faturechi ProPublica, June 1, 2017, 8 a.m. Then-Rep. Tom Price, … Continue reading →

Posted in FDA, Trump, USDA | Tagged , , , | Leave a comment